Floatz logo

Therapeutic Asset Ratings

3,232 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Nivolumab
Melanoma
Bristol-Myers SquibbP4BB (69)
Nivolumab
Renal Cell Carcinoma
Fred Hutchinson Cancer CenterP4BB (69)
Noradrenaline
Cardiovascular Disorder
Helse FonnaP4BB (69)
Olaparib
Ovarian Cancer
Shandong UniversityP4BB (69)
Olea europaea oil
Radiodermatitis
Cairo UniversityP4BB (69)
Oliceridine
Burn
University of TennesseeP4BB (69)
Oliceridine
Respiratory Failure
University of TennesseeP4BB (69)
OXALIPLATIN
Colorectal Carcinoma
First Affiliated Hospital of Zhejiang UniversityP4BB (69)
Oxcarbazepine
Epilepsy
University of PittsburghP4BB (69)
Oxodotreotide
Digestive System Neuroendocrine Tumor, Grade 1/2
Vanderbilt-Ingram Cancer CenterP4BB (69)
Oxytocin
Chronic Pain Syndrome
Wake Forest University Health SciencesP4BB (69)
Palbociclib
Breast Neoplasm
Eli Lilly and CompanyP4BB (69)
PALMITIC MONOETHANOLAMIDE
Chronic Prostatitis
Clinica Urologica Molinette - Città della Saliute e della ScienzaP4BB (69)
Pancrelipase
Cystic Fibrosis
Anagram Therapeutics, Inc.P4BB (69)
PEGASPARGASE
Hemophagocytic Syndrome
Beijing Tongren HospitalP4BB (69)
Pegloticase
Tumor Lysis Syndrome
M.D. Anderson Cancer CenterP4BB (69)
Pembrolizumab
Melanoma
Biocon Biologics UK PLCP4BB (69)
Pembrolizumab
Renal Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP4BB (69)
Pembrolizumab
Non-Small Cell Lung Carcinoma
City of Hope Medical CenterP4BB (69)
Phentermine
Essential Hypertension
VIVUS LLCP4BB (69)
PHYTONADIONE, (E)-(±)-
Esophageal Varices With Bleeding
Tanta UniversityP4BB (69)
Plerixafor
Non-Hodgkin Lymphoma
Thomas Jefferson UniversityP4BB (69)
Pomalidomide
Plasma Cell Myeloma
National Cancer Institute (NCI)P4BB (69)
Ppsv23
Pneumococcal Infection
Poitiers University HospitalP4BB (69)
PREDNISONE TABLETS
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP4BB (69)
Showing 1126 to 1150 of 3,232 assets
PreviousPage 46 of 130Next